A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus

Title
A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus
Authors
Keywords
-
Journal
ARTHRITIS AND RHEUMATISM
Volume 61, Issue 9, Pages 1168-1178
Publisher
Wiley
Online
2009-08-27
DOI
10.1002/art.24699

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started